Symrise Launches Cellexora MD, an Upcycled Apple-Derived Plant Exosome

Symrise announced Cellexora MD, a plant-derived exosome ingredient, on April 2, 2026, then showcased it at in-cosmetics Global 2026 in Paris (April 14-16). It is the second major plant exosome to debut at the same event in the same quarter, alongside dsm-firmenich’s Exovive Lift.

Upcycling as the source

Cellexora MD draws exosomes from organic Italian apple side streams. Residuals from apple beverages, vinegar, and food processing become a resource rather than waste, completing an upcycling model. Natural origin content is certified at 100% per ISO 16128-2.

Two distinguishing features. First, no dedicated agricultural input or stem cell culture is required because the exosomes are recovered from existing food industry residuals. Second, focusing on a single species (apple) keeps vesicle composition consistent and quality control simpler.

Positioned as “true” exosomes

Symrise frames Cellexora MD as a “true” exosome, meaning it presents an actual extracellular vesicle structure rather than a marketing label. The company says these vesicles mediate communication between keratinocytes, fibroblasts, and macrophages, supporting multi-layered skin protection.

A 30-day clinical study measured three wrinkle metrics: length, depth, and volume. Specific numerical results were not disclosed, but the use of standardized wrinkle tools sets this announcement apart from earlier plant exosome marketing. Reported benefits include enhanced collagen production, soothing effects, and visible reduction of aging signs.

The physical form is a white, odorless, highly water-soluble powder, suitable for varied formulation contexts.

A signal from Symrise’s Care & Wellness division

Notably, Cellexora MD sits inside Symrise’s Care & Wellness business. The company positions the ingredient within a “connected care model” linking skin health, gut microbiome, and holistic wellness.

This is not just marketing language. At the same event, ExoLab Italia presented exosome-based nutricosmetics including Skin Probio, Gut Pro, and Antiage. Plant exosomes are no longer confined to topical skincare. The category is extending into “edible exosomes” as well.

Symrise calls this “healthspan-driven skin care,” signaling intervention at the mechanism layer rather than just correction of visible aging signs.

Two exosomes in one quarter

Two major plant exosomes (dsm-firmenich’s three-source composite and Symrise’s single-source apple line) launching at the same event mark a transition. Plant exosomes have crossed the threshold from marketing category to clinical-data-bearing ingredient class.

Within twelve months, head-to-head trials, vesicle concentration standardization, and cargo analysis publications will add definition. “Contains exosomes” on a label will give way to plant species, vesicle counts, and cargo specifications. This launch is the starting point.